- Home
- SNY vs HCA Comparison
SNY vs HCA Comparison
Compare SNY & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNY | HCA |
|---|---|---|
| Founded | 1994 | 1968 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5B | 105.5B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | SNY | HCA |
|---|---|---|
| Price | $42.47 | $390.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 20 |
| Target Price | $58.00 | ★ $511.84 |
| AVG Volume (30 Days) | ★ 3.5M | 1.7M |
| Earning Date | 04-23-2026 | 04-24-2026 |
| Dividend Yield | ★ 3.47% | 0.72% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | N/A | ★ 7.15 |
| Revenue | N/A | ★ $75,600,000,000.00 |
| Revenue This Year | $3.49 | $5.11 |
| Revenue Next Year | $6.10 | $4.86 |
| P/E Ratio | ★ $6.14 | $54.16 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $40.89 | $330.00 |
| 52 Week High | $52.68 | $556.52 |
Technical Indicators
Market Signals| Indicator | SNY | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 48.65 |
| Support Level | $42.30 | $356.89 |
| Resistance Level | $48.76 | $399.38 |
| Average True Range (ATR) | 0.70 | 10.14 |
| MACD | -0.14 | 3.78 |
| Stochastic Oscillator | 40.03 | 76.25 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.